Often characterized by involuntary motor or vocal tics, Tourette syndrome typically appears in childhood and affects up to ...

Baylen Dupree is saying “hell no” to a potential treatment for her Tourette syndrome. In PEOPLE's exclusive look at the ...

The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients.

By blocking dopamine-1 receptors, ecopipam is expected to reduce the repetitive and compulsive behaviors seen in Tourette syndrome.

In the renewal announcement clip, Dupree's eyes widen as she reacts, "No! No, really?" She then pumps her fist, flashing the ...

Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist Medical Center have been recognized by the ...